Weather

95°F9:25 PM

Health

1 read

UMC CEO Jacob Cintron's Salary and Bonus Surge Amid Hospital Growth

El Paso Matters•Thursday, December 18, 2025 at 10:32 PM•Priscilla Totiyapungprasert

Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at El Paso Matters

AI Summary

Jacob Cintron, the CEO of University Medical Center (UMC) in El Paso, has received a substantial 14% salary increase, raising his annual pay to $1,128,582, retroactive to October 1, 2026. The UMC board approved this raise along with a bonus of $346,449, reflecting Cintron's performance and the hospital's expanding budget of $1.9 billion for 2026. This increase aligns with a broader trend of rising CEO salaries in the healthcare sector, despite a slower wage growth for healthcare workers. UMC has also opened new facilities and enhanced services, contributing to a significant revenue increase of 29% over the previous year. The board emphasized the importance of competitive compensation to attract top talent in the healthcare industry.

Key Details: • Cintron's salary increase is retroactive to October 1, 2026. • UMC's 2026 budget is $1.9 billion, up $200 million from last year. • The board approved a bonus of $346,449 for Cintron based on performance metrics. • UMC opened its first urgent care clinic near Horizon City this year. • Public meetings are held monthly; participation details are available online.

umc healthcare salary ceo hospital

People & Organizations

Jacob CintronKristina MenaHorizon CityUniversity Medical CenterAnna PerezLinda Yee ChewMiguel FernandezSteve DeGroatIsidro TorresChristina PazUniversity Medical CenterEl Paso County Commissioners CourtPaso del Norte Health FoundationEl Paso Chamber of CommerceNAMI El Paso

Related Articles

Major Savings for Medicare Part D Seniors on 10 Essential Medications in 2026

Starting January 1, 2026, seniors enrolled in Medicare Part D will benefit from reduced costs on 10 high-priced medications that are crucial for managing chronic conditions. This change is significant as it aims to alleviate the financial burden on elderly patients who depend on these essential drugs. The adjustments in pricing are part of broader efforts to make healthcare more affordable for seniors. Medicare beneficiaries should prepare to take advantage of these savings as they plan their healthcare budgets for the upcoming year.

Upcoming Drug Price Increases Affecting Over 350 Medications in 2026

A recent analysis indicates that the prices of more than 350 medications in the United States are set to increase in 2026, despite commitments from various drug manufacturers to provide more affordable options under new policies from the Trump administration. This potential rise in costs could significantly impact patients relying on these medications, raising concerns about access to necessary treatments. As the healthcare landscape continues to evolve, residents should stay informed about these changes and consider discussing their medication options with healthcare providers.

Trump Reveals High Aspirin Dosage Amid Health Concerns in Recent Interview

In a recent interview with The Wall Street Journal, President Donald Trump disclosed that he takes a higher dosage of aspirin than recommended by his doctors, attributing visible bruises on his hands to this practice. At 79 years old, Trump faces increasing scrutiny regarding his health and fitness for office, especially after the appearance of bruises and swelling during public events. His physician, Dr. Sean Barbabella, stated that Trump takes 325 milligrams of aspirin daily, which exceeds the typical recommendation of 75 to 100 milligrams. Medical experts express concern over the potential risks associated with such a high dosage, emphasizing the need for transparency regarding Trump's health. The White House maintains that Trump is in excellent health, with evaluations showing cardiovascular health significantly better than his age.

Measles Cases Surge to Highest Level in Three Decades, CDC Warns

The Centers for Disease Control and Prevention (CDC) has reported a significant increase in measles cases, reaching the highest levels seen in 30 years. This resurgence raises concerns about the potential revocation of the disease's elimination status, which was declared in the U.S. in 2000. The rise in cases could have serious implications for public health, particularly affecting communities with lower vaccination rates. Residents are urged to ensure their vaccinations are up to date to help prevent further outbreaks.